"At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023", the latest report from medical market research publisher Kalorama Information, examines a range of both at-home tests and home collection tests. The report is now available for purchase.
ARLINGTON, Va., June 15, 2023 /PRNewswire-PRWeb/ -- The Home in vitro diagnostic (IVD) testing market is not new, but it had primarily been limited to glucose and pregnancy testing. COVID-19 testing has opened the door for home infectious disease testing and more. The market is detailed in "At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023", the latest report published by leading medical market research firm Kalorama Information.
The global Home IVD testing market was valued at $28.9 billion in 2022, with the largest portion of that attributed to glucose testing and COVID-19 testing. The Home IVD market increased 9% over 2021, largely due to increases in the infectious disease segment, namely COVID-19 testing sales. Although it is hard to predict the future of Home IVD diagnostic testing, Kalorama has attempted to provide the best trajectory for this market based on available data and industry information.
The Home IVD testing market is a growing market facilitated by the proliferation of COVID-19 tests that have entered the market since the pandemic began. This has spurred insurance companies to provide reimbursement for home COVID-19 tests, which could help to save money in the long run on health costs.
Advancements in technology have provided new methods of testing such as nasal and buccal swabs and increased accuracy of immunoassays and molecular tests. Some of the barriers to the market have been addressed but there is still more to be done.
Consumers are taking a greater role in their own healthcare with testing being a big part of that. Consumers also experienced growing confidence in performing their own tests due to the proliferation of COVID-19 tests during the pandemic. It is Kalorama Information's assumption that telemedicine and internet connection have also played a role in consumer empowerment making it easier to reach the provider to discuss the home test results.
Growth of the Home IVD testing market will likely continue in the short term and has a very good foundation for continuing to grow in the future. At the present time, it is hard to speculate the long-term trajectory of Home IVD testing but there are positive signs that the market will continue to build on the successes of glucose, pregnancy and COVID-19 testing.
For more information or to purchase this market research report visit : https://kaloramainformation.com/product/at-home-diagnostic-testing-markets-and-trends-covid-19-fob-glucose-hiv-and-other-tests-2023/.
ABOUT KALORAMA INFORMATION
Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Kalorama Information produces 30 reports a year. The firm offers a Knowledge Center, which provides access to all published reports.
Media Contact
Daniel Granderson, Kalorama Information, 703-778-3080, [email protected]
SOURCE Kalorama Information
Share this article